Skip to main content

How should we balance the risks and benefits of using AI in healthcare?

Healthcare
United States
Started March 26, 2026

In this edition of STAT Health Tech: An AI chatbot for surgical patients got 'breakthrough' status from FDA, HHS phases out Claude, and more

🗳️ Join the conversation
3 statements to vote on • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 3/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Posted by will Mar 26, 2026
While AI can offer benefits in healthcare, we must be cautious about its implementation. The potential for errors in AI-driven recommendations could jeopardize patient safety, especially if healthcare providers rely too heavily on these tools without sufficient oversight.
0 total votes
CLAIM Posted by will Mar 26, 2026
Many patients may not be comfortable interacting with AI systems regarding their health. Human empathy and understanding are vital in patient care, and AI cannot replicate the critical emotional support that healthcare providers offer.
0 total votes
CLAIM Posted by will Mar 26, 2026
As generative AI tools are integrated into healthcare settings, it is essential to establish clear guidelines for their use. What regulatory frameworks should be in place to balance innovation with patient safety and ethical considerations?
0 total votes

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us